Objective-Reactive oxygen species (ROS) act as signaling molecules during angiogenesis; however, the mechanisms used for such signaling events remain unclear. Stromal cell-derived factor-1α (SDF-1α) is one of the most potent angiogenic chemokines. Here, we examined the role of ROS in the regulation of SDF-1α-dependent angiogenesis. Approach and Results-Bovine aortic endothelial cells were treated with SDF-1α, and intracellular ROS generation was monitored. SDF-1α treatment induced bovine aortic endothelial cell migration and ROS generation, with the majority of ROS generated by bovine aortic endothelial cells at the leading edge of the migratory cells. Antioxidants and nicotinamide adenine dinucleotide phosphate oxidase (NOX) inhibitors blocked SDF-1α-induced endothelial migration. Furthermore, knockdown of either NOX5 or p22phox (a requisite subunit for NOX1/2/4 activation) significantly impaired endothelial motility and tube formation, suggesting that multiple NOXs regulate SDF-1αdependent angiogenesis. Our previous study demonstrated that c-Jun N-terminal kinase 3 activity is essential for SDF-1α-dependent angiogenesis. Here, we identified that NOX5 is the dominant NOX required for SDF-1α-induced c-Jun N-terminal kinase 3 activation and that NOX5 and MAP kinase phosphatase 7 (MKP7; the c-Jun N-terminal kinase 3 phosphatase) associate with one another but decrease this interaction on SDF-1α treatment. Furthermore, MKP7 activity was inhibited by SDF-1α, and this inhibition was relieved by NOX5 knockdown, indicating that NOX5 promotes c-Jun N-terminal kinase 3 activation by blocking MKP7 activity. Conclusions-We conclude that NOX is required for SDF-1α signaling and that intracellular redox balance is critical for SDF-1α-induced endothelial migration and angiogenesis. (Arterioscler Thromb Vasc The online-only Data Supplement is available with this article at http://atvb.ahajournals.org/lookup/suppl/
R eactive oxygen species (ROS) are generated not only as by-products of mitochondrial metabolism but also by a variety of cellular enzyme systems, including nicotinamide adenine dinucleotide phosphate (NADPH) oxidase (NOX), uncoupled endothelial nitric oxide synthase (eNOS), xanthine oxidase, and arachidonic acid-metabolizing enzymes. When cellular production of ROS exceeds the antioxidant capacity of cardiovascular cells, proteins, lipids, and nucleic acids become damaged and may eventually contribute to the development of cardiovascular diseases such as atherosclerosis, hypertension, diabetic cardiovascular complications, and ischemic-reperfusion injury. Conversely, low concentrations of ROS play a critical role in regulating cardiovascular functions such as angiogenesis and tissue repair. [1] [2] [3] ROS are required for vascular endothelial growth factor (VEGF)induced endothelial migration, proliferation, and tube formation. 4, 5 During ischemia and reperfusion, ROS generation promotes capillary tube formation in human microvascular endothelial cells 6 and the heart, 7 whereas inhibiting ROS through treatment with antioxidants or superoxide dismutases blocks vascularization and growth of tumors. 8, 9 The precise molecular mechanisms, however, by which ROS mediate angiogenic responses are incompletely understood.
NOX is an important enzymatic source of ROS. There are 7 Nox genes identified in mammalian organisms: Nox1-5 and dual oxidases 1 to 2. NOXs are expressed in endothelial cells and other cardiovascular cells and regulate various functions such as cell survival, growth, apoptosis, differentiation, angiogenesis, and contractility. 10 The NOX enzymes are heteroprotein complexes (except NOX5) with different regulatory mechanisms, tissue distribution, and subcellular localization and downstream targets. A membrane regulatory subunit, p22phox, is associated with NOXs 1, 2, and 4 and is required for their activity. 10 NOXs 1 and 2 share a common overall structure with a short cytoplasmic N terminus, which is required for activation, [11] [12] [13] and 6 transmembrane domains. 14, 15 In contrast, NOX4 is constitutively active and is regulated by gene expression. 16 Interestingly, unlike other NOXs, NOX5 possesses a longer cytoplasmic N terminus containing Ca 2+binding motifs, resulting in its activation by Ca 2+ elevation. 17 ROS generated by NOXs 1, 2, and 4 mediate angiogenic effects in response to angiogenic factors such as VEGF and angiotensin II. 10 However, the exact function of these NOXs and the underlying mechanisms by which they mediate their actions remain unknown, partly because of inconsistent published observations and context-dependent efficacy.
Stromal cell-derived factor 1α (SDF-1α, also called C-X-C motif chemokine ligand 12) is one of the most potent angiogenic CXC chemokines. Our previous studies have shown that SDF-1α requires MKP7 S-nitrosylation to activate c-Jun N-terminal kinase (JNK) 3 and promote endothelial migration and angiogenesis. 18 MKP7 belongs to a subgroup of protein tyrosine phosphatases, which are widely recognized as targets of ROS that can be oxidized at redox-sensitive cysteine residues resulting in the inhibition of phosphatase activity after growth factor treatment. [19] [20] [21] MKP7 possesses a critical cysteine in its catalytic pocket that is highly sensitive to oxidation because of its low pKa. 22 Therefore, we hypothesized that NOX-generated ROS may oxidize and inhibit MKP7, thereby regulating SDF-1α-dependent JNK3 activity and angiogenesis. By performing a series of biochemical and cell biological assays, we have developed strong evidence that suggests that NOXs, including NOX5, are novel positive regulators of SDF-1α-induced endothelial migration and angiogenesis.
Materials and Methods
Materials and Methods are available in the online-only Supplement.
Results

SDF-1α Induces Transient Generation of ROS in BAECs
Our previous studies demonstrated that MKP7 S-nitrosylation and subsequent inhibition are required for SDF-1α-induced endothelial migration and angiogenesis. 18 MKP7 activity can also be modified and inhibited through oxidation of a critical redox-sensitive cysteine in its catalytic pocket. 22 NOXs 1, 2, and 4 are the major source of ROS in endothelial cells. 23 In addition, they regulate angiogenesis in response to growth factors such as VEGF and angiotensin II. 10 However, the exact function of these NOXs remains elusive, and whether NOX-generated ROS regulate SDF-1α-dependent signaling is unknown. We hypothesized that NOX-generated ROS may be another mechanism by which MKP7 activity is inhibited during SDF-1α-dependent angiogenesis. To investigate the role of NOX-generated ROS in SDF-1α-dependent angiogenesis, we first examined ROS generation in bovine aortic endothelial cells (BAECs) after SDF-1α treatment. The fluorescent dyes CM-H 2 DCFDA (the chloromethyl derivative of 2′,7′-dichlorodihydrofluorescein diacetate) and dihydroethidium were used to monitor and determine the level of hydrogen peroxide and superoxide (O 2 · − ) production, respectively, in BAECs after treatment with SDF-1α. When cells were treated with SDF-1α for 5 minutes, an increase in fluorescent dichlorofluorescein (DCF) signal was detected in BAECs by confocal microscopy ( Figure 1A ) and by flow cytometry (from 0.01% cells positive under control conditions to 15.45% cells in response to SDF-1α; Figure 1B ; Figure IA in the online-only Data Supplement). Furthermore, this SDF-1α-induced DCF signal was inhibited by polyethylene glycol catalase but not the inhibitors of NOS, L-NAME (L-N G -nitroarginine methyl ester), and that of cyclooxygenase, diclofenac (Figure IB-IE in the online-only Data Supplement), suggesting that this detected DCF signal is because of hydrogen peroxide generation but not the formation of peroxynitrites or arachidonate metabolites. SDF-1α treatment of BAECs also resulted in O 2 · − generation, detected by the appearance of fluorescent ethidium generated from oxidation of dihydroethidium. SDF-1α-induced superoxide production rapidly increased ≈2 fold, peaking at 5 minutes after the SDF-1α treatment began ( Figure 1C ). Furthermore, the superoxide level was induced in a dose-dependent manner ( Figure 1D ). To determine whether ROS were generated during SDF-1α-induced endothelial cell migration, a wound scratch assay was performed to visualize the active migratory process of BAECs after SDF-1α treatment. Consistent with the observations above, SDF-1α treatment of BAECs resulted in generation of a fluorescent DCF signal that was most prominent at the leading edge of the BAECs where active migration takes place ( Figure 1E ). These data suggest that ROS are generated in response to SDF-1α treatment in BAECs and that this ROS generation correlates with the SDF-1α-dependent migratory response.
Antioxidants Inhibit SDF-1α-Induced JNK3 Activation and Endothelial Migration
To determine whether the ROS generation seen at the leading edge of the migrating BAECs is necessary for SDF-1αinduced migration, the wound scratch assay was repeated in the presence of the 2 antioxidants N-acetyl-l-cysteine and ebselen. As shown in Figure 2A , SDF-1α-induced BAEC migration was significantly inhibited by pretreatment of cells with either N-acetyl-l-cysteine or ebselen, indicating that ROS generation is required for SDF-1α-induced cell migration.
NOXs Are required for SDF-1α-Induced Angiogenesis
Recent evidence indicates that NOXs are the major sources of ROS in endothelial cells. 23 SDF-1α treatment of BAECs resulted in ROS generation that was associated with SDF-1α-induced cell migration, we next examined whether NOXs were also involved in these events. Using the Boyden chamber migration assay, we observed that SDF-1α treatment increased BAEC migration from 13±1 to 48±1 cells per field ( Figure 2B ) but that SDF-1α-induced migration could be completely inhibited by the 2 general NOX inhibitors diphenylene iodonium (DPI) and apocynin ( Figure 2B ), indicating that NOX enzyme-dependent ROS generation is essential for SDF-1α-mediated BAEC migration. Four different NOX enzymes (NOXs 1, 2, 4, and 5) are expressed in vascular endothelial cells such as BAECs ( Figure IIA in the online-only Data Supplement). 10 NOXs 1, 2, and 4 have each been linked to angiogenic responses; however, the underlying molecular mechanisms behind these events are not completely understood. Furthermore, because previous experiments have been largely performed in rodent cells that do not express NOX5, the role of NOX5 in angiogenesis is yet to be determined. Therefore, to determine which NOX was responsible for SDF-1α-induced angiogenesis, we first examined the effect of knockdown of NOX5 or p22phox, a crucial component of NOX1/2/4 active enzyme complexes, 10 on SDF-1α-induced endothelial migration in BAECs. p22phox or NOX5 small-interfering RNA (siRNA) specifically decreased the RNA and protein levels of p22phox or NOX5, respectively, but not other NOXs in BAECs ( Figure IIB and IIC in the online-only Data Supplement). Similar to antioxidants or NOX inhibitors, knockdown of either NOX5 or p22phox decreased superoxide generation ( Figure IID in the online-only Data Supplement). More excitingly, their knockdown blocked endothelial migration induced by SDF-1α ( Figure 2C ), suggesting that multiple NOXs, including NOX5, are involved in SDF-1α-induced endothelial migration. To assess the effect of NOX depletion on tube formation, BAECs were transfected with siRNA specific for either NOX5 or p22phox, and the effect on SDF-1α-induced tube formation in Matrigel was analyzed. Seventy-two hours after transfection with p22phox siRNA, NOX5 siRNA, or control siRNA, BAECs were plated on Matrigel in medium containing 100 ng/mL SDF-1α. SDF-1α treatment significantly enhanced tube formation in BAECs transfected with control siRNA, with the tube number increasing from 12±3 to 68±10 tubes per field ( Figure 2D ). In contrast, SDF-1αinduced tube formation was significantly blocked in BAECs transfected with either p22phox siRNA or NOX5 siRNA by 4.5-or 3.4-fold, respectively ( Figure 2D ). To confirm this antiangiogenic effect of p22phox and NOX5 siRNAs, we also performed a spheroid-sprouting angiogenesis assay using BAECs treated with SDF-1α. This assay measures the sprouting and network formation of gel-embedded aggregated endothelial cells. Endothelial spheroids were prepared with BAECs transfected with different siRNAs and then stimulated with SDF-1α. The total number of sprouts from each spheroid was counted and compared with control cells. As shown in Figure IIE in the onlineonly Data Supplement, SDF-1α-treated BAECs showed a 3.4-fold increase in sprouts/spheroids compared with control BAECs. However, this increase in SDF-1α-induced sprout formation was inhibited in BAECs transfected with either p22phox or NOX5 siRNA. The data collected from the Matrigel and spheroid-sprouting angiogenesis assays strongly suggest that multiple NOXs, including NOX5 and probably NOX1/2/4, are critical mediators of SDF-1αdependent angiogenesis in BAECs. Reactive oxygen species (ROS) are generated after stromal cellderived factor-1α (SDF-1α) treatment. Bovine aortic endothelial cells (BAECs) were treated with SDF-1α (100 ng/mL) for 5 minutes, and ROS production was detected by CM-H 2 DCFDA (the chloromethyl derivative of 2′,7′-dichlorodihydrofluorescein diacetate; A and B) or dihydroethidium staining (C and D). A, Representative images of DCFDA-stained cells. Scale bar, 10 μm. B, Representative flow cytometry data obtained for H 2 O 2 measurement that was detected as green fluorescence after CM-H 2 DCFDA staining. This is an overlay picture of 2 samples: the control (blue) and 100 ng/mL SDF-1α treated for 5 minutes (gray). C and D, BAECs were treated with SDF-1α in 100 ng/mL for different time periods (C) or different concentrations for 5 minutes (D). O 2 · − production was quantified as ethidium bromide (EB) fluorescence. *P<0.05, compared with control BAECs (n=3). E, Representative images of an endothelial cell monolayer with a scratch wound. Cells were treated with SDF-1α (100 ng/mL) for 5 minutes and fixed for CM-H 2 DCFDA staining. Scale bar, 50 μm.
NOX5, But Not NOX1/2/4, Is Required for JNK3 Activation Induced by SDF-1α
We have previously demonstrated that JNK3 is an important component of SDF-1α-mediated endothelial migration and angiogenesis. 18 Because the data above demonstrate that NOX-generated ROS also play an essential role in SDF-1α-dependent angiogenesis (Figure 2 ), we tested whether SDF-1α-induced JNK3 activation was influenced by NOXdependent ROS generation. All 3 antioxidants, butylated hydroxyanisole, N-acetyl-l-cysteine, and ebselen, inhibited SDF-1α-induced JNK phosphorylation in BAECs ( Figure 3A ; Figure IIIA in the online-only Data Supplement). SDF-1αinduced JNK3 activation was also inhibited by the NOX inhibitors DPI and apocynin ( Figure 3B ). To test which NOX isoform was involved in SDF-1α-induced JNK3 activation, BAECs were transfected with p22phox siRNA, NOX5 siRNA, or control siRNA. Activation of SDF-1α-induced JNK3 activation was dramatically decreased by knockdown of NOX5 but not by knockdown of p22phox ( Figure 3C ). Furthermore, ectopic expression of NOX5 in BAECs was sufficient to activate JNK3 at baseline and augmented JNK3 activation after SDF-1α stimulation ( Figure 3D ). The inhibitory effect of NOX inhibitors and NOX5 siRNAs on SDF-1α-induced JNK3 activation was further confirmed in human vascular endothelial cells (Figure IIIB-IIID in the online-only Data Supplement). Furthermore, we also observed that extracellular signal-regulated kinase (ERK) activation in response to SDF-1α was also blocked by NOX inhibitors and NOX5 siRNAs, but not p22phox siRNAs in both BAECs and human vascular endothelial cells ( Figure  IIIC , IIIE, and IIIF in the online-only Data Supplement). In summary, these data suggest that NOX5, but not NOX1/2/4, is required and sufficient for SDF-1α-induced JNK3 and ERK activation. In addition to the effects seen by SDF-1α, we also observed that other cytokines, including tumor necrosis factor (TNF) 1α and interleukin-1β but not basic fibroblast growth factor, evoke an increase in superoxide generation in BAECs (Figure IVA-IVC in the online-only Data Supplement). Furthermore, the activation of JNK by TNF1α was inhibited by NOX5 siRNA but not p22phox siRNA ( Figure IVD in the online-only Data Supplement). The activation of NOXs 1, 2, and 4 and ROS generation regulate VEGF-induced angiogenesis. 24 However, the involvement of NOX5 has not been tested.
To assess the effect of NOX5 depletion on VEGF-induced tube formation, human vascular endothelial cells were transfected with NOX5 siRNA. VEGF increased the formed tube number in control cells. However, the knockdown of NOX5 inhibited tube formation in response to VEGF significantly ( Figure IVE and IVF in the online-only Data Supplement). Taken together, we speculate that the NOX5-dependent signaling pathway may represent a relatively general mechanism for growth factors and cytokines.
ROS induce the expression of numerous genes including those that code for antioxidant proteins. One such antioxidants, heme oxygenase-1 (HO-1) has previously been linked to SDF-1-induced angiogenesis. 25 Therefore, we were interested to test whether HO-1 expression in BAECs is also regulated by NOXs. Excitingly, when BAECs were treated with SDF-1α for 8 hours, the protein level of HO-1 increased dramatically, which is consistent with a previous report. 25 However, the induction in HO-1 protein level was inhibited in cells that were transfected with NOX5 siRNAs, but not p22phox Nicotinamide adenine dinucleotide phosphate oxidases (NOXs) inhibit stromal cell-derived factor-1α (SDF-1α)-induced migratory and angiogenic responses in bovine aortic endothelial cells (BAECs). A, A wound healing assay was performed with BAECs. Cell monolayers were scratched, incubated with N-acetyl-l-cysteine (NAC; 10 mmol/L) or ebselen (Ebs; 40 μmol/L) for 30 minutes, and then treated with SDF-1α (100 ng/mL). Twenty-four hours later, cells were fixed and images were taken. The level of cell migration into the scratch wound was quantified as the recovered area. *P<0.05, compared with control cells; #P<0.01, compared with control cells that were treated with SDF-1α (n=3). B, Boyden chamber analysis of BAEC migration was performed using 100 ng/mL SDF-1α as the chemoattractant. *P<0.001, compared with control cells without SDF-1α. #P<0.001, compared with control cells with SDF-1α (n=3). C, Boyden chamber analysis of BAEC migration was performed using 100 ng/ mL SDF-1α as the chemoattractant. BAECs were transfected with p22phox, NOX5, or control small interfering RNA (siRNA). *P<0.01, compared with control cells without SDF-1α. #P<0.01, compared with control cells with SDF-1α (n=3). D, In vitro Matrigel angiogenesis assays were performed with BAECs that were transfected with p22phox, NOX5, or control siRNAs. SDF-1α (100 ng/mL) was used to induce tube formation. Images of formed tubes were taken, and tube numbers were counted. *P<0.001, compared with control cells without SDF-1α. #P<0.05, compared with control cells with SDF-1α. Scale bar, 50 μm. Apo indicates apocynin; and DPI, diphenylene iodonium. siRNAs ( Figure V in the online-only Data Supplement), indicating that HO-1 is likely one of the downstream mediators for the angiogenic effect of NOX5 in BAECs.
Hyperglycemia Disrupts SDF-1α-Dependent ROS Generation and JNK3 Activation
Increased oxidative stress is associated with many chronic diseases, including diabetes mellitus and related cardiovascular diseases. 26 SDF-1α is a dominant angiogenic factor under multiple pathological conditions such as diabetic retinopathy. 27 Therefore, we investigated the effect of elevated ROS level on SDF-1α-dependent signaling when BAECs were cultured under elevated glucose conditions. Comparing the cells cultured under normal glucose concentration (7 mmol/L glucose), the incubation of cells with ≈3.3-fold higher glucose level for 3 days significantly increased the intracellular ROS level ( Figure 4A ). Reports have demonstrated that NOX1/2/4, but not NOX5, are responsible for the elevation of ROS level in response to high glucose in vascular cells. 26, 28, 29 Interestingly, when cells were cultured under normal glucose concentrations, SDF-1α increased JNK3 activation and the antioxidant ebselen blocked it. However, when cells were cultured with a higher concentration of glucose, the response of JNK3 activation to SDF-1α was blunted ( Figure 4B ). Together, these data suggest that SDF-1α-dependent NOX5 activation and its downstream signaling are inhibited under hyperglycemic conditions and that the regulatory roles of NOX1/2/4 and NOX5 are likely altered when cellular glucose homeostasis is disrupted.
NOX5 Is Associated With MKP7 in BAECs and Inhibits MKP7 Activity
The preceding experiments indicate that NOX5 is the dominant NOX responsible for SDF-1α-induced JNK3 activation. However, the molecular mechanisms underlying this NOX5dependent signaling event are not clear. S-nitrosylation of the catalytic cysteine of MKP7, which blocks its phosphatase activity, is required for the SDF-1α-induced activation of JNK3. 18 Interestingly, the labile cysteine at the catalytic center of MKPs is also susceptible to oxidation. 22 Oxidation of this cysteine by TNFα-generated ROS is critical for activation of JNK1 and the apoptotic effects of TNFα. 22 This prompted us to examine whether ROS generated by NOX5 could result in oxidation of MKP7. In order for NOX5generated ROS to efficiently oxidize MKP7, NOX5 and MKP7 would need to be in close proximity. 30 To determine the relative localization of MKP7 and NOX5, Flagtagged MKP7 and green fluorescent protein (GFP)-tagged NOX5 were transfected into BAECs and their localization determined using confocal microscopy. Both flag-tagged μmol/L) for 30 minutes and then treated with SDF-1α (100 ng/mL) for 10 minutes to activate JNK3. Cell lysates were used for Western blotting to detect the activation of JNK3 using the phospho-JNK antibody. The phosphorylation of JNK was interpreted as JNK3 phosphorylation because JNK3 is the major JNK moiety activated by SDF-1α in endothelial cells in our system. 18 B, BAECs were incubated with NOX inhibitor diphenylene iodonium (DPI; 10 μmol/L) or apocynin (Apo; 5 mmol/L) for 30 minutes and then treated with SDF-1α (100 ng/mL) for 10 minutes to activate JNK3. Cell lysates were used for Western blotting to detect the activation of JNK3. C, BAECs were transfected with p22phox small interfering RNA (siRNA), NOX5 siRNA, or control siRNA. Three days later, cells were treated with SDF-1α (100 ng/mL) for 10 minutes to activate JNK3. Cell lysates were used for Western blotting to detect the activation of JNK3. D, BAECs were transfected with Myc-tagged NOX5 or control vector. Two days later, cells were treated with SDF-1α (100 ng/mL) for 10 minutes to activate JNK3. Cell lysates were used for Western blotting to detect the activation of JNK3. *P<0.05, compared with control cells without SDF-1α; #P<0.05, compared with control cells with SDF-1α (n=3). Figure 5B ) and GFP-tagged NOX5 colocalized to the plasma membrane and cytoplasm of BAECs ( Figure 5A) , indicating a spatial proximity that would be favorable for NOX5 oxidation of MKP7. To determine whether these 2 proteins associate directly, immunoprecipitation assays were performed on transfected cells. As shown in Figure 5C , Flagtagged MKP7 was detected in a protein complex immunoprecipitated with Myc-tagged NOX5 but not Myc-p22phox, suggesting that MKP7 was associated with NOX5 specifically in human embryonic kidney 293 cells. The reverse coimmunoprecipitation experiment confirmed the association of MKP7 with NOX5 ( Figure VIA in the online-only Data Supplement). Coimmunoprecipitation of endogenous MKP7 and NOX5 from BAECs confirmed that, under basal conditions, MKP7 and NOX5 were associated together ( Figure 5D ). However, after SDF-1α treatment, the proteins dissociated, suggesting a possible mechanism for reversible SDF-1α regulation of MKP7 ( Figure 5D and 5E). To identify which region of MKP7 was responsible for NOX5 binding, a series of MKP7 deletion mutants ( Figure 5B ) were engineered. Using coimmunoprecipitation experiments once again, we determined that MKP7 (318-665) but not MKP7 (1-317) was associated with NOX5 ( Figure VIB in the online-only Data Supplement). Further mutations of the 318-665 fragment revealed that MKP7 (415-440; indicated by black arrow in Figure 5B ) was required for association with NOX5 ( Figure 5F ). Taken together, these data demonstrate that MKP7 and NOX5 associate in BAECs and that this association is dynamically regulated by SDF-1α.
MKP7 (
Having established that NOX5 and MKP7 do associate with one another in BAECs, we next sought to determine whether ROS generated from SDF-1α-induced activation of NOX5 oxidizes MKP7, resulting in the inhibition of MKP7 phosphatase activity and subsequent activation of JNK3. An in vitro MKP7 activity analysis was performed using active JNK3 protein and MKP7 concentrated from cell lysates after our established protocol. 18 At baseline, Flag-tagged MKP7 protein demonstrated strong phosphatase activity as shown by the decrease in JNK3 phosphorylation ( Figure 6A ). Similar to our previous report, 18 the treatment of SDF-1α blocked 42.8% of MKP7 phosphatase activity ( Figure 6A and 6B). However, when cells were treated with the NOX inhibitor DPI, MKP7 retained high phosphatase activity at both baseline and after SDF-1α treatment of cells ( Figure 6A and 6B). Similarly, NOX5 knockdown via transfection of cells with NOX5-specific siRNAs relieved the inhibitory effect of SDF-1α on MKP7 phosphatase activity ( Figure 6C and 6D). These data suggest that ROS generated by NOX5 inhibit MKP7 phosphatase activity, offering one plausible mechanism by which NOX5 promotes SDF-1α-induced JNK3 activation.
Our previous study has demonstrated that MKP7 can be nitrosylated by nitric oxide generated by eNOS after eNOS is activated in response to SDF-1α treatment. 18 Similar to eNOS activation leading to the inhibition of MKP7 phosphatase activity, 18 NOX5 activation blocked MKP7 activity and enhanced JNK3 activation. Therefore, we tested whether the blockage of both eNOS and NOX5 activities would result in synergistic inhibitory effects on JNK3 activation. BAECs were transfected with both siRNAs of eNOS and NOX5, and the changes in JNK3 activity were determined. Interestingly, the knockdown of NOX5 or eNOS blocked the activation of JNK3. However, the knockdown of both NOX5 and eNOS did not further significantly inhibit the activation of JNK3 ( Figure VII in the online-only Data Supplement). It suggests that NOX5 and eNOS might work on the same pathway upstream of JNK3 activation. Reports have shown that NOX5 induces eNOS activity possibly by enhancing eNOS:hsp90 binding or increasing intracellular calcium level. 31 Another regulatory mechanism for their interaction could be that both eNOS and NOX5 regulate MKP7 activation.
Taken all together, our data identify NOX5 as a novel component of SDF-1α-dependent JNK3 activation and support the hypothesis that NOX-generated ROS are important mediators of SDF-1α-dependent angiogenesis. More importantly, both nitrous and oxidative stresses, and therefore the intracellular redox status, are important for SDF-1α-dependent signaling and endothelial activation in response to pathophysiologic conditions such as hyperglycemia. The response to stromal cell-derived factor-1α (SDF-1α) is blunted when bovine aortic endothelial cells (BAECs) were cultured in the presence of high glucose concentrations. BAECs were cultured in media containing either normal glucose concentration (7 mmol/L glucose+23 mmol/L mannitol) or high glucose concentration (30 mmol/L glucose). Three days later, cells were incubated with ebselen (Ebs; 40 μmol/L) for 30 minutes and then treated with SDF-1α (100 ng/mL) for 5 minutes to determine reactive oxygen species generation and for 10 minutes to determine c-Jun N-terminal kinase 3 (JNK3) activation. A, O 2 · − production was quantified as ethidium bromide fluorescence. B, JNK3 activation was determined by Western blotting. *P<0.05, compared with control BAECs with low glucose and without SDF-1α. #P<0.05, compared with control cells without Ebs (n=3). p-JNK indicates phospho-JNK; and NS, not significant.
Discussion
NOXs are well accepted as being novel players in the regulation of angiogenesis. However, the underlying mechanisms by which they exert their actions have not been completely elucidated. Using NOX inhibitors and NOX5-specific siRNA, we have demonstrated a requisite role for NOX5 in the regulation of SDF-1α-dependent JNK3 activation and subsequent endothelial activation and angiogenesis. This is the first report demonstrating that NOX-generated ROS are required for the angiogenic effects of SDF-1α in endothelial cells. Furthermore, we observed that multiple cytokines including SDF-1α, TNF1α, and interleukin-1β induced superoxide generation, and the activation of JNK by TNF1α was inhibited by NOX5 siRNA ( Figure IV in the online-only Data Supplement). This recapitulates previous evidence demonstrating that NOXgenerated ROS play an important role in angiogenic signaling in response to growth factors and cytokines. 10 Given the lack of NOX5 expression in rodents, the functional roles of NOX5 have not been well studied. However, our data hint at an unexpected role for NOX5 in the regulation of human pathophysiology that is associated with angiogenesis.
Increased oxidative stress is associated with many chronic diseases, including diabetes mellitus and related cardiovascular diseases. 26 Our observation that SDF-1α-dependent JNK3 activation was blunted under hyperglycemic conditions (Figure 4) indicates that NOX-dependent ROS generation normally required for angiogenesis is dysregulated in a microenvironment where significantly higher levels of oxidative stress are present. Therefore, both beneficial and detrimental roles of ROS, whose generation might be because of the activation of different enzyme and nonenzyme systems, on endothelial pathophysiology need further clarification to improve the efficacy and safety of therapeutic strategies involving use of antioxidants and NOX inhibitors. In addition, NOX5 is upregulated in some cancers, such as its deletion mutant constructs. The black arrow indicates the fragment of MKP7 responsible for its minimal association with NOX5. C, Human embryonic kidney (HEK) 293 cells were transfected with Flag-MKP7, Myc-NOX5, or Myc-p22phox constructs. One day later, total cell lysates (TCL) were used for immunoprecipitation for Myc-NOX5 and Myc-p22phox and immunoblotting for Flag-MKP7. D, BAECs were treated with stromal cell-derived factor-1α (SDF-1α; 100 ng/mL) for 5 minutes and harvested for immunoprecipitation for NOX5 and immunoblotting for MKP7. E, The MKP7 proteins associated with NOX5 in BAECs were quantified as the fold change, compared with the control cells. *P<0.05, compared with control cells without SDF-1α (n=3). F, HEK293 cells were transfected with different Flag-MKP7 mutants and Myc-NOX5 constructs. One day later, TCL were used for immunoprecipitation for Myc-NOX5 and immunoblotting for Flag-MKP7. JNK indicates c-Jun N-terminal kinase 3; and p-JNK, phosphor-JNK.
prostate cancer, esophageal adenocarcinoma, and hairy cell leukemia. [32] [33] [34] DPI, a general NOX inhibitor, potently inhibits the migration, proliferation, and invasion of prostate cancer cells by modulating the activity of growth signaling pathways, including ERK1/2 and p38, and causing cell cycle arrest. 35 Based on our finding that NOX-generated ROS participate in angiogenic events, it is also possible that DPI blocks angiogenesis within the tumor, thereby increasing its usefulness as an antitumor therapy. Similarly, blockade of the SDF-1α/CXCR4 signaling axis, including NOX5, may represent a promising additional or alternative target for the treatment of some forms of cancer such as rectal carcinoma and colorectal cancer in which SDF-1α levels are seen to increase after recurrence of tumors after chemotherapy and anti-VEGF therapy. 36, 37 Targeting NOX5 in the SDF-1α pathway may also be useful in treatment against atherosclerosis. In the vascular system, NOX5 is predominantly expressed in endothelial cells but is also detected in smooth muscle cells. In atherosclerotic aortas, the expression level of endothelial NOX5 is increased. 38 Given our data demonstrating that NOX5 is involved in angiogenic responses in endothelial cells, it is possible that the elevation in NOX5 expression in atherosclerotic lesions exacerbates plaque formation by promoting new vessel formation. Blockade of NOX5 may therefore be one mechanism by which the development of atherosclerotic plaques can be cured.
The data presented in this report are the first demonstration that NOXs are activated by the SDF-1α/CXCR4 signaling axis. All forms of NOX (NOXs 1, 2, 4, and 5) are expressed in endothelial cells. 10 Previous studies have demonstrated that p22phox is required for activity of NOX1, NOX2, and NOX4. 10 Because knockdown of p22phox also blocked SDF-1α-induced endothelial migration and angiogenesis, we conclude that NOX1, NOX2, and NOX4, in addition to NOX5, can be activated by SDF-1α in endothelial cells. That said, their activation and downstream effectors are likely to be different based on their individual molecular structures. NOX5 possesses additional cytosolic N-terminal EF hands for binding calcium, rendering it able to be activated by calcium, probably because of the fact that the binding of calcium to these EF hands, a common Ca 2+ -binding motif, relieves the autoinhibitory loop on the activity domain of NOX5. 39 CXCR4, a G-protein-coupled receptor, is ligated by SDF-1α, and its activation initiates a series of signaling processes including an increase in calcium influx. 40 Alternative calcium-independent mechanisms have also been reported to promote calcium sensitization and activation of NOX5. 39 Whether calcium influx or other mechanisms of calcium sensitization is required for NOX5 activation by SDF-1α remains to be determined. In contrast to NOX5, the activation of NOX1, NOX2, and NOX4 is regulated differentially by small G proteins and multiple kinases. Rac GTPases are required for both NOX1 and NOX2 activity. [41] [42] [43] [44] Protein kinase C, phosphatidylinositide 3-kinase, and Src are kinases that regulate the assembly of the NOX2 oxidase complex by recruiting p47phox bound to p67phox and p40phox; Akt, protein kinase C, and protein kinase A negatively modulate NOX1 activity. 10 Unlike NOX1 and NOX2, NOX4 exhibits constitutive activity. NOX4 agonists acutely increase its activity, probably through the fast induction of protein expression, increasing the available NADPH pool, or by promoting NOX4's association with its receptors. 10 The diverse range of activators and repressors of NOX 1, 2 and 4 activity suggest that numerous upstream mediators could be activated in response to SDF-1α. Therefore, further experiments are needed to characterize the detailed molecular mechanisms by which NOX1, NOX2, and NOX4 are activated by SDF-1α.
The downstream mediators of NOX1, NOX2, NOX4, and NOX5 responsible for promoting the effects of SDF-1α-induced endothelial migration and angiogenesis are unknown. By using NOX inhibitors and specific siRNAs of Figure 6 . MKP7 activity is regulated by nicotinamide adenine dinucleotide phosphate oxidase (NOX) 5. A, Results of an in vitro phosphatase assay using active c-Jun N-terminal kinase 3 (JNK3) protein as the substrate. Bovine aortic endothelial cells (BAECs) were transfected with Flag-MKP7 and then treated with diphenylene iodonium (DPI; 10 μmol/L) for 30 minutes and followed by stromal cell-derived factor-1α (SDF-1α; 100 ng/mL) treatment for 5 minutes. The cell lysates concentrated for Flag-tagged MKP7 protein were used for in vitro phosphatase assays. B, Quantitative analysis of results from in vitro phosphatase assays of MKP7 in Figure 5A based on 3 independent experiments. *P<0.05, compared with control cells. C, Results of an in vitro phosphatase assay using active JNK3 protein as the substrate. BAECs were transfected with Flag-MKP7, and NOX5 or control small interfering RNA (siRNA) and then treated with SDF-1α for 5 minutes. The cell lysates concentrated for Flag-tagged MKP7 protein were used for in vitro phosphatase assays. D, Quantitative analysis of results from in vitro phosphatase assays of MAP kinase phosphatase 7 (MKP7) in Figure 5C NOX5 and p22phox, we have demonstrated that JNK3 and ERK are specific mediators for NOX5 in the regulation of SDF-1α-induced angiogenesis (Figures 2 and 3 ; Figures II and III in the online-only Data Supplement). Furthermore, we observed that the induction of HO-1, a known mediator of SDF-1α-induced angiogenesis, is mediated by NOX5 ( Figure V in the online-only Data Supplement). However, whether JNK3 and ERK act as upstream mediators in response to SDF-1α to induce HO-1 expression still needs further investigation. Other than the downstream mediators that are mentioned above, multiple other pathways have been characterized as downstream mediators of NOX1/2/4 in the regulation of cell proliferation and migration. For example, Akt is reported to mediate NOX-promoted cell proliferation responses, 6, [45] [46] [47] whereas the PPARα (peroxisome proliferatoractivated receptor-alpha) pathways have been implicated as downstream effectors for NOX1's effect on cell migration. 48 The interaction of NOX2 and the scaffold protein IQGAP1 (IQ motif containing GAP1) leads to the accumulation of NOX2 at the leading edge of migrating endothelial cells, 49 and NOX4 is reported to regulate eNOS expression in endothelial cells. 50 Whether these pathways are involved in cell migration and proliferation associated with SDF-1α activation of these NOXs still needs further investigation.
The data presented in this report are a continuation of our recent observations that JNK3 is a major mediator of SDF-1α-dependent endothelial migration and that MKP7, the JNK3 phosphatase, is nitrosylated by nitric oxide and this nitrosylation leads to inhibition of its phosphatase activity. 18 Here, we present data demonstrating that MKP7 activity is also inhibited by NOX inhibitors or NOX5 siRNAs, suggesting that the intracellular redox status is critical for maintaining cellular functions for endothelial cells. Cysteine oxidation is one important mechanism by which ROS modulate protein function, and the oxidation of the catalytic cysteine on MKP7 has been reported to be required for TNFα-induced JNK activation. 22, 51 Therefore, we propose that MKP7 is oxidized by NOX5-generated ROS after SDF-1α administration, which in turn inhibits MKP7 phosphatase activity and sustains JNK3 activation. All MKPs share this cysteine-containing catalytic motif, suggesting they are similarly regulated by the intracellular redox status. In addition to cysteine oxidation, other amino acids such as lysine, proline, arginine, and threonine can also be oxidized, and these modifications are recognized as being important for the pathogenesis of many degenerative diseases. 52 Future studies aimed at further characterizing the role of protein oxidation may provide essential information that helps to explain the pathophysiologic mechanism of oxidative stress.
